A groundbreaking series of class-action lawsuits have been filed against some of the largest U.S. cannabis operators, accusing them of prioritizing profits over public health by falsely marketing recreational marijuana as a medical cure-all while suppressing information about its potential dangers.
The legal actions, which are drawing comparisons to the historic lawsuits against Big Tobacco in the 1990s, target industry giants including Cresco Labs, Green Thumb Industries, and Verano Holdings. Filed in federal and state courts in Illinois and Connecticut, the lawsuits were brought forward by a coalition of law firms representing consumers across more than a dozen states with legal adult-use markets.
The Core Allegations: Deceptive Marketing vs. Scientific Reality
The central claim of the expansive, 300-plus-page federal complaint is that these multistate operators (MSOs) systematically misled the public by promoting recreational cannabis products as safe treatments for various ailments.
According to the lawsuits:
- Companies aggressively marketed their high-THC products to an unsuspecting public as remedies for conditions like insomnia, autoimmune disorders, neuropathy, anxiety, and depression, despite marijuana not being FDA-approved to treat these ailments.
- The industry allegedly failed to warn consumers about the severe risks associated with frequent use of high-potency THC, which research has linked to serious mental health disorders, including schizophrenia, psychosis, bipolar disorder, and suicidal ideation.
- The marketing strategies adopted by these companies allegedly echo the historical tactics of the tobacco industry, utilizing branding and emotional wellness language to create a misleading aura of safety and therapeutic benefit.
The plaintiffs argue they suffered economic harm, claiming they overpaid or would not have purchased the products had they known the full scope of the potential health risks. They are seeking unspecified financial damages and a court order to force companies to halt claims regarding the health or therapeutic benefits of their recreational products.
The Push for Transparency
The legal effort is being spearheaded in part by Patrick Kenneally, a former Illinois county prosecutor who has a history of challenging the cannabis industry. Kenneally previously forced dispensaries in McHenry County to display in-store signs warning customers about the mental health dangers of cannabis.
“This is analogous to tobacco in the 1950s and the 1960s before people had the knowledge with respect to the health dangers of tobacco,” Kenneally stated, expressing confidence that the science linking cannabis to mental health risks is “unassailable”.
The lawsuit emphasizes that while there are FDA-approved synthetic THC drugs and CBD treatments for specific conditions, there is a lack of evidence supporting the broad, curative claims often associated with commercial marijuana products.
Industry Response
The targeted cannabis companies have pushed back against the allegations. A spokesperson for Verano Holdings called the lawsuit part of a “broader litigation campaign” and stated that the claims mirror those already rejected by courts in previous legal actions. Verano asserted that it complies with state regulations and plans to defend itself vigorously, pointing to the federal government’s recent steps to formally recognize the accepted medical use of cannabis. Cresco Labs declined to comment on active litigation.
If successful, the lawsuit could radically alter how cannabis is marketed and sold in the United States, potentially leading to stringent warning labels and a complete overhaul of the industry’s advertising playbook.
Dabbin-Dad Newsroom
